Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.52%
SPX
+0.53%
IXIC
+0.52%
FTSE
-0.86%
N225
-1.44%
AXJO
-0.81%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
146.42M
Dividend Yield
0.00%
P/E Ratio
-1.95
EPS
-38.81
Revenue
251.00K
Avg. Volume
24.40M

Recently from Cashu

No Cashu articles
Artiva Biotherapeutics currently has no Cashu-related articles

About

What does ARTV do?
Artiva Biotherapeutics, based in San Diego, focuses on NK cell-based therapies for autoimmune diseases and cancers, with its lead candidate AlloNK in Phase I/Ib trials. The company went public on July 19, 2024.
Sector
💻 Health Care
IPO
CEO
Employees
105
Headquarters
California, USA
Website
https://www.artivabio.com
Stocks
Health Care
artv
Artiva Biotherapeutics
NASDAQ: ARTV
+3.24 (+116.97%)
6.01
USD
At close at Oct 17, 20:44 UTC
Summary
News
Signals
Benchmarks
Financials